Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A

Leukemia Research

Volumn 32, Issue 7, 2008, Pages 1112-1123

  Horie, Akiyoshi ^a   Akimoto, Miho ^a   Tsumura, Hiroto ^a   Makishima, Makoto ^b   Taketani, Takeshi ^a   Yamaguchi, Seiji ^a   Honma, Yoshio ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cotylenin A; Differentiation; Leukemia cell; Lithocholic acid acetate; Mitogen activated protein kinase

Indexed keywords

ANTINEOPLASTIC AGENT; BILE ACID; COTYLENIN A; DITERPENE; LITHOCHOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL DIVISION; DITERPENES; DNA PRIMERS; HL-60 CELLS; HUMANS; LITHOCHOLIC ACID; MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 41949090235     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.12.004     Document Type: Article

References (40)

1. Huan M., Ye Y., Chen S., Chai J., Lu J., Lin Z., et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72 (1988) 567-572
2. Degos L., Chomienne C., Daniel M.T., Berger R., Dombret H., Fenaux P., et al. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid. Lancet 336 (1990) 1440-1441
3. Ohno R., Naoe T., Hirano M., Kobayashi M., Hirai H., Tubaki K., et al., The leukemia Study Group of the Ministry of Health and Welfare. Treatment of myelodysplastic syndromes with all-trans retinoic acid. Blood 81 (1993) 1152-1154
4. 3. Proc Natl Acad Sci USA 78, (1981) 4990-4994
5. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102 (1981) 937-943
6. 3 and its fluorinated analogues. Cancer Res 44 (1984) 5624-5628
7. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80 (1983) 201-204
8. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 69 (1985) 1399-1407
9. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129 (1991) 832-837
10. Pakkala S., De Vos S., Elstner E., Rude R.K., Uskokovic M., Binderup L., et al. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk Res 19 (1995) 65-72
11. Makishima M., Lu T.T., Xie W., Whitefield G.K., Domoto H., Evans R.M., et al. Vitamin D receptor as an intestinal bile acid sensor. Science 296 (2002) 1313-1316
12. Adachi R., Honma Y., Masuno H., Kawana K., Shimomura I., Yamada S., et al. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J Lipid Res 46 (2005) 46-57
13. 3 in vivo and in vitro. Mol Endocrinol 18 (2004) 2660-2671
14. 3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101 (2004) 1589-1594
15. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
16. Nehring J.A., Zierold C., and Deluca H.F. Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci USA 104 (2007) 10006-10009
17. Honma Y., Fujita Y., Kasukabe T., Hozumi M., Sampi K., Sakurai M., et al. Induction of differentiation of human acute non-lymphoid leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60. Eur J Cancer Clin Oncol 19 (1983) 251-261
18. Koeffler H.P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62 (1983) 709-721
19. 3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells. Leuk Res 20 (1996) 781-789
20. Makishima M., Okabe-Kado J., and Honma Y. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1α-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea. Br J Cancer 77 (1998) 33-39
21. 3. Exp Hematol 26 (1998) 198-206
22. Yamamoto-Yamaguchi Y., Yamada K., Ishii Y., Asahi K., Tomoyasu S., and Honma Y. Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator. Br J Haematol 112 (2001) 697-705
23. Sassa T., Tojyo T., and Munakata K. Isolation of a new plant growth substance with cytokinin-like activity. Nature 227 (1970) 379
24. Sassa T., Togashi M., and Kitaguchi T. The structures of cotylenin A, B, C, D and E. Agric Biol Chem 39 (1975) 1735-1744
25. Yamada K., Honma Y., Asahi K., Sassa T., Hino K., and Tomoyasu S. Differentiation of human acute myeloid leukaemia cells in primary culture in response to cotylenin A, a plant growth regulator. Br J Haematol 114 (2001) 814-821
26. Honma Y., Ishii Y., Sassa T., and Asahi K. Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells. Leuk Res 27 (2003) 1019-1025
27. Ishii Y., Sakai S., and Honma Y. Pyridinyl imidasole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells. Leuk Res 25 (2001) 813-820
28. Ishii Y., Kasukabe T., and Honma Y. Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim Biophys Acta 1745 (2005) 156-165
29. Yen A., Roberson M.S., Varvayanis S., and Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58 (1998) 3163-3172
30. 3-induced differentiation of HL60 cells. J Cell Biochem 80 (2001) 471-482
31. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92 (1995) 7686-7689
32. Ishii Y., Kiyota H., Sakai S., and Honma Y. Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones. Leukemia 18 (2004) 1413-1419
33. Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 280 (2005) 18120-18129
34. CIP1/WAF1. Cancer Res 63 (2003) 3637-3645
35. WAF1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation. Mol Cells 13 (2002) 125-129
36. KIP1. Blood 93 (1999) 2225-2233
37. Sato N., Fukushima N., Matsubayashi H., and Goggins M. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23 (2004) 1531-1538
38. Pinto A., Attadia V., Fusco A., Ferrara F., Spada O.A., and Di Fiore P.P. 5-Aza-2′-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemia. Blood 64 (1984) 922-929
39. 3. Br J Haematol 112 (2001) 315-326
40. Petti M.C., Fazi I., Gentile M., Diverio D., De Fabritiis P., De Propris M.S., et al. Complete remission through blast cell differentiation in PLZF/RARa-positive acute promyelocytic leukemia: in vitro and in vivo studies. Blood 100 (2002) 1065-1067